Abstract:Esophageal squamous cell carcinoma (ESCC) is the most common histological subtype of esophageal cancer and one of the most aggressive types of malignancy, with a high rate of mortality. Early diagnosis and treatment may improve the prognosis of ESCC and, thus, survival rates. As a significant tumor suppressor, p53 is closely associated with apoptosis and the differentiation of cancer cells. The present study evaluated the expression levels of the p53 protein and the clinical significance in patients presenting with ESCC. The p53 protein expression level of 64 paired ESCC and tumor-adjacent normal tissues was evaluated using western blot analysis. In addition, immunohistochemistry (IHC) was performed to detect the p53 expression level in specimens from 118 paraffin-embedded cancerous tissues. The correlation of the p53 expression level with the clinicopathological parameters and prognosis of the ESCC patients was also analyzed. The p53 protein was identified to be highly expressed in the ESCC tissue, with western blot analysis demonstrating that the expression level of p53 in the cancerous tissue was 1.89 times that of the tumor-adjacent normal tissue (P<0.001); furthermore, IHC indicated that there was a marked positive expression of p53 in the ESCC tissue (49.15%). The expression level of p53 protein was identified to be significantly correlated with the tumor grade (P<0.001), N stage (P=0.010). Additionally, the higher level of p53 expression was found to be associated with a poor survival rate in the ESCC patients (P=0.0404). The univariate analysis showed that the survival time of patients was significantly correlated with the T stage (RR=3.886, P<0.001), N stage (lymph node metastasis; RR=3.620, P<0.001) and TNM stage (RR=3.576, P<0.001). Furthermore, the multivariate analysis revealed that the T stage (RR=3.988, P<0.001) and N stage (RR=4.240, P=0.004) significantly influenced the overall survival of the ESCC patients.

Expression of MDR1mRNA detected and its correlation with p53 in esophageal carcinoma by in situ hybridization

Expressions and Significances of Topoisomeraseⅱ and Multidrug Resistance-Associated Protein in Human Esophageal Squamous Cell Carcinoma

Study on relationship between mutant p53 and multidrug resistance gene 1 in gastric cancer

The clinical significance of p53 and pRb signal pathway in esophageal cancer patients

Expressions of P53 and Nm23 Proteins in Oral Squamous Cell Carcinoma

Relation Between Mutant P53 and Multidrug Resistance in Gastric Cancer

Expressions of MDR1 and HIF-1α in Esophageal Carcinoma and Their Clinical Significance

Expression of P53, P16 and Cyclooxygenase-2 in Esophageal Cancer with Tissue Microarray

Characterization and correlation of 14-3-3σ and P53 protein expressions in multi-stage carcinogenesis of esophageal squamous cell carcinoma

Expressions of p53 and hMSH2 in colon carcinoma

The determination of p53 protein and VEGF and MVD in esophageal squamous cell carcinoma and adjacent noncancerrous tissue and their relations

Elevated P53 Expression Levels Correlate with Tumor Progression and Poor Prognosis in Patients Exhibiting Esophageal Squamous Cell Carcinoma.

[Expression of Retinoic Acid Receptor-Beta Mrna and P16, P53, Ki67 Proteins in Esophageal Carcinoma and Its Precursor Lesions].

Expression of COX-2 and p53 protein in esophageal carcinoma and their significance

Expression of p53 and vascular endothelial growth factor in esophageal squamous cell carcinoma and their clinical significance]

High Expression of MDR1 is Correlated with Poor Prognosis for Common Malignancies

The Research Progress of Esophageal Cancer and C-Myc PTEN P33/ing1 MDR1/P-gP

Elevated Expression of P63 Protein in Human Esophageal Squamous Cell Carcinomas

Expression of MnSOD Mrna and Protein in Esophageal Squamous Cell Carcinoma and Its Clinical Significance

Expression of PD-L1 and its prognostic role in patients with esophageal squamous cell carcinoma

Investigation on the Potential Correlation Between TP53 and Esophageal Cancer